AMW GmbH

AMW GmbH is a specialty pharmaceutical company based near Munich, Germany. It is a market leader in developing biodegradable slow-release drug delivery systems—primarily implants—and first-to-market generics. The company's two main commercialized products are goserelin and leuprorelin peptide hormone implants for oncology indications. These are distributed globally through licensing partners. The pipeline includes both proprietary and partnered projects targeting oncology, neurology, endocrinology, ophthalmology, pain treatment, breast cancer, Parkinson’s disease, diabetes and more. Clinical results support improved medication adherence due to the long-lasting nature of their implantable formulations.